Feng K - Search Results

1

Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.

Lv M, Chen M, Zhang R, Zhang W, Wang C, Zhang Y, Wei X, Guan Y, Liu J, Feng K, Jing M, Wang X, Liu YC, Mei Q, Han W, Jiang Z. Lv M, et al. Among authors: feng k. Cell Res. 2020 Nov;30(11):966-979. doi: 10.1038/s41422-020-00395-4. Epub 2020 Aug 24. Cell Res. 2020. PMID: 32839553 Free PMC article. Clinical Trial.

2

Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment.

Guo Y, Feng K, Wang Y, Han W. Guo Y, et al. Among authors: feng k. Protein Cell. 2018 Jun;9(6):516-526. doi: 10.1007/s13238-017-0394-6. Epub 2017 Mar 13. Protein Cell. 2018. PMID: 28290053 Free PMC article. Review.

3

Increased IFNγ⁺ T Cells Are Responsible for the Clinical Responses of Low-Dose DNA-Demethylating Agent Decitabine Antitumor Therapy.

Li X, Zhang Y, Chen M, Mei Q, Liu Y, Feng K, Jia H, Dong L, Shi L, Liu L, Nie J, Han W. Li X, et al. Among authors: feng k. Clin Cancer Res. 2017 Oct 15;23(20):6031-6043. doi: 10.1158/1078-0432.CCR-17-1201. Epub 2017 Jul 13. Clin Cancer Res. 2017. PMID: 28706011 Clinical Trial.

4

Phase Ib/II study of safety and efficacy of low-dose decitabine-primed chemoimmunotherapy in patients with drug-resistant relapsed/refractory alimentary tract cancer.

Chen M, Nie J, Liu Y, Li X, Zhang Y, Brock MV, Feng K, Wu Z, Li X, Shi L, Li S, Guo M, Mei Q, Han W. Chen M, et al. Among authors: feng k. Int J Cancer. 2018 Sep 15;143(6):1530-1540. doi: 10.1002/ijc.31531. Epub 2018 Apr 26. Int J Cancer. 2018. PMID: 29663379 Free PMC article. Clinical Trial.

5

Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study.

Feng K, Liu Y, Zhao Y, Yang Q, Dong L, Liu J, Li X, Zhao Z, Mei Q, Han W. Feng K, et al. J Immunother Cancer. 2020 Jun;8(1):e000367. doi: 10.1136/jitc-2019-000367. J Immunother Cancer. 2020. PMID: 32487569 Free PMC article. Clinical Trial.

6

Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report.

Fan H, Lu X, Wang X, Liu Y, Guo B, Zhang Y, Zhang W, Nie J, Feng K, Chen M, Zhang Y, Wang Y, Shi F, Fu X, Zhu H, Han W. Fan H, et al. Among authors: feng k. J Immunol Res. 2014;2014:371087. doi: 10.1155/2014/371087. Epub 2014 May 21. J Immunol Res. 2014. PMID: 24963497 Free PMC article. Clinical Trial.

7

Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer.

Feng K, Guo Y, Dai H, Wang Y, Li X, Jia H, Han W. Feng K, et al. Sci China Life Sci. 2016 May;59(5):468-79. doi: 10.1007/s11427-016-5023-8. Epub 2016 Mar 11. Sci China Life Sci. 2016. PMID: 26968708

8

Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial.

Liu Y, Guo Y, Wu Z, Feng K, Tong C, Wang Y, Dai H, Shi F, Yang Q, Han W. Liu Y, et al. Among authors: feng k. Cytotherapy. 2020 Oct;22(10):573-580. doi: 10.1016/j.jcyt.2020.04.088. Epub 2020 Jun 9. Cytotherapy. 2020. PMID: 32527643 Free article. Clinical Trial.

9

Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors.

Wang Z, Li N, Feng K, Chen M, Zhang Y, Liu Y, Yang Q, Nie J, Tang N, Zhang X, Cheng C, Shen L, He J, Ye X, Cao W, Wang H, Han W. Wang Z, et al. Among authors: feng k. Cell Mol Immunol. 2021 Sep;18(9):2188-2198. doi: 10.1038/s41423-021-00749-x. Epub 2021 Aug 11. Cell Mol Immunol. 2021. PMID: 34381179 Free PMC article. Clinical Trial.

10

An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells.

Zhang Y, Zhang W, Dai H, Wang Y, Shi F, Wang C, Guo Y, Liu Y, Chen M, Feng K, Zhang Y, Liu C, Yang Q, Li S, Han W. Zhang Y, et al. Among authors: feng k. Sci China Life Sci. 2016 Apr;59(4):379-85. doi: 10.1007/s11427-016-5035-4. Epub 2016 Mar 24. Sci China Life Sci. 2016. PMID: 27009300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,995 results

Search Page